Skip to main content

Year: 2025

Tree Island Steel Announces Third Quarter 2025 Results

VANCOUVER, British Columbia, Nov. 13, 2025 (GLOBE NEWSWIRE) — Tree Island Steel (”Tree Island” or the ”Company”) (TSX: TSL) announced today its financial results for the nine months ended September 30, 2025. For the three-months ended September 30, 2025, revenues, net of freight and distribution costs, were lower by $14.8 million to $36.8 million from $51.6 million in 2024. This was due to the impact of the U.S. tariffs on Canada to U.S. sales of wire and wire products which was partially mitigated by increased sales within Canada. Average selling prices in certain categories were higher, however, gross profit was lower by $0.3 million compared to prior year due to lower production volumes. Through higher average selling prices in certain categories, head count and cost reductions, adjusted EBITDA improved...

Continue reading

Mount Logan Capital Inc. Announces Third Quarter 2025 Financial Results

Declared quarterly distribution of $0.03 per common share in the fourth quarter of 2025, the first shareholder distribution for Mount Logan as a US registrant Asset Management segment generated $9.2 million in Fee Related Earnings (“FRE”)1 for the trailing twelve months ended September 30, 2025 Generated $5.2 million of Spread Related Earnings (“SRE”)2 for the trailing twelve months ended September 30, 2025, which reflects 0.7% of spread earnings on Ability’s assets All amounts are stated in United States dollars, unless otherwise indicated NEW YORK, Nov. 13, 2025 (GLOBE NEWSWIRE) — Mount Logan Capital Inc. (Nasdaq: MLCI) (“Mount Logan” or the “Company”) announced today its financial results for the third quarter ended September 30, 2025. Third Quarter 2025 HighlightsCompletion of business combination with 180 Degree Capital...

Continue reading

Data Storage Corporation Postpones 2025 Third Quarter Business Update Conference Call

MELVILLE, N.Y., Nov. 13, 2025 (GLOBE NEWSWIRE) — Data Storage Corporation (Nasdaq: DTST) (“DSC” and the “Company”), today announced the postponement of its 2025 third quarter business update conference call, previously scheduled for November 14, 2025. The rescheduling is necessary to allow time for accounting adjustments related to the recently completed sale of the Company’s CloudFirst subsidiary. DSC is working diligently to finalize these adjustments and will provide an updated date and time for the conference call as soon as they are available. About Data Storage CorporationData Storage Corporation (Nasdaq: DTST), once the tender offer is complete, plans to invest in and support businesses, including, but not limited to, GPU Infrastructure-as-a-Service (IaaS), AI-driven software applications, cybersecurity, and voice/data telecommunications....

Continue reading

Dundee Corporation Announces Acquisition of Shares of New Found Gold Corp.

TORONTO, Nov. 13, 2025 (GLOBE NEWSWIRE) — In accordance with regulatory requirements, Dundee Corporation (TSX: DC.A) (“Dundee”) announces that it has acquired an aggregate of 36,722,569 common shares and 7,655,829 warrants of New Found Gold Corp. (TSXV: NVG, NYSE-A: NFGC) (the “Issuer”) pursuant to the completed plan of arrangement between the Issuer and Maritime Resources Corp. Immediately prior to the acquisition of securities described in this news release, Dundee did not own any shares or warrants of the Issuer. Immediately following the transaction that triggered the requirement to file this news release, Dundee owns or controls an aggregate of 36,722,569 common shares and 7,655,829 warrants of the Issuer representing an approximate 10.88% interest of the Issuer on an undiluted basis and a 12.86% interest of the Issuer on...

Continue reading

Stardust Power Announces Q3 2025 Financial Results

GREENWICH, Conn., Nov. 13, 2025 (GLOBE NEWSWIRE) — Stardust Power Inc. (“Stardust Power” or the “Company”) (Nasdaq: SDST), an American developer of battery-grade lithium carbonate, today announced its results for the third quarter ended September 30, 2025.   Third Quarter 2025 Business Updates and Subsequent Events Operational highlights for the third quarter of 2025 include:The FEL-3 engineering report was completed for the Muskogee, Oklahoma lithium refinery, detailing Phase 1 capacity of 25,000 metric tons per annum (mtpa) (expandable to 50,000 mtpa), and estimated CapEx of approximately $500 million (including owner’s cost, contingency, and escalation), which is about $200 million below the prior estimate. The report outlined a 24-month construction timeline and a 90% probability of cost achievement. An independent third-party...

Continue reading

Aptose Reports Third Quarter 2025 Results

Tuspetinib Continues to Demonstrate Excellent Safety and Complete Responses in the TUSCANY Clinical Trial of Tuspetinib in AML Triple Drug Frontline Therapy at Increased Dose Levels Patients are Now Being Treated at 160 mg Dose of TuspetinibSAN DIEGO and TORONTO, Nov. 13, 2025 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (“Aptose” or the “Company”) (TSX: APS and OTC: APTOF), a clinical-stage precision oncology company developing a tuspetinib (TUS)-based triple drug frontline therapy to treat patients with newly diagnosed acute myeloid leukemia (AML), today announced financial results for the third quarter ended September 30, 2025, and provided a corporate update. “Tuspetinib in combination with VEN+AZA standard treatment (TUS+VEN+AZA) has been highly active and so well tolerated in newly diagnosed AML patients with 40 mg, 80 mg,...

Continue reading

Stantec reports strong third quarter 2025 results, delivering over 17% growth in adjusted earnings per share

HighlightsNet revenue of $1.7 billion, an increase of 11.8% compared to Q3 2024 Adjusted EBITDA1 increase of 17.8% to $323.4 million and adjusted EBITDA margin1 of 19.0%, a 100 basis point increase over Q3 2024 Diluted EPS of $1.32 and adjusted EPS1 of $1.53, up 46.7% and 17.7%, respectively, compared to Q3 2024 Contract backlog increased to $8.4 billion, up 14.9% year-over-year Increases full year adjusted EBITDA margin guidance, reflecting the strong performance year-to-date and expectations for Q4 2025.EDMONTON, Alberta and NEW YORK, Nov. 13, 2025 (GLOBE NEWSWIRE) — Stantec (TSX, NYSE:STN), a global leader in sustainable engineering, architecture and environmental consulting, released its third quarter 2025 results today which were driven by the continued demand for Stantec’s services, its diversified business model,...

Continue reading

Enthusiast Gaming Reports Q3 2025 Financial Results

Adjusted EBITDA from continuing operations of $1.2 million for the nine months ended September 30, 2025, compared to a loss of $0.1 million in the year ago period Completed sale of Direct Sales Media Business and related creative assets in Q3, resulting in a gain on sale of subsidiaries and assets of $5.5 million Gross margin of 86.9% in Q3 2025, up 1,810 bps from Q3 2024 TORONTO, Nov. 13, 2025 (GLOBE NEWSWIRE) — Enthusiast Gaming Holdings Inc. (“Enthusiast Gaming” or the “Company”) (TSX: EGLX), a digital publisher focused on building tools, platforms, and experiences for gamers, today announced financial results for the three months ended September 30, 2025 (“Q3 2025”). “In three short months we pushed squarely into profitability, increased our cash position significantly, and embraced our true identity as an R&D-driven,...

Continue reading

DPM Metals Reports Record Third Quarter 2025 Financial Results; Vareš Positioned for Significant Value Creation

TORONTO, Nov. 13, 2025 (GLOBE NEWSWIRE) — DPM Metals Inc. (TSX: DPM, ASX: DPM) (ARBN: 689370894) (“DPM” or the “Company”) announced its operating and financial results for the third quarter and first nine months ended September 30, 2025. Highlights (Unless otherwise stated, all monetary figures in this news release are expressed in U.S. dollars, and all operational and financial information contained in this news release is related to continuing operations.)Record free cash flow generation: Generated $147.7 million of free cash flow1 and $184.5 million of cash provided from operating activities of continuing operations in the third quarter. Record adjusted net earnings per share: Reported third quarter adjusted net earnings1 of $129.2 million ($0.73 per share1) and net earnings from continuing operations of $96.0 million ($0.54...

Continue reading

SAB BIO Reports Third Quarter Financial Results and Recent Business Highlights

Initiated registrational Phase 2b SAFEGUARD trial of SAB-142 in new-onset, Stage 3 autoimmune T1D patientsMultiple SAFEGUARD trial sites activated; on-track to dose first patient by year-endRecent data presented at EASD and IPSAD provide further validation for SAB-142 as a novel, potentially best-in-class, disease-modifying, immunotherapeutic approach to redefine treatment of Stage 3 T1DStrong cash position with operational runway through 2028, enabling completion of registrational Phase 2b SAFEGUARD studyMIAMI, Nov. 13, 2025 (GLOBE NEWSWIRE) — SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes (T1D) and other autoimmune diseases, today announced financial results for the third quarter ending September 30, 2025,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.